UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Informing primary care reform in Greece: patient expectations and experiences (the QUALICOPC study)

BMC health services research, 2017-04, Vol.17 (1), p.255-255, Article 255

2017

Volltextzugriff (PDF)

General Practitioners’ intention to prescribe and prescribing patterns in selected European settings: The OTCSOCIOMED project

Health policy (Amsterdam), 2015-09, Vol.119 (9), p.1265-1274

2015

Volltextzugriff (PDF)

Self-efficacy, stress levels and daily style of living among older patients with type 2 diabetes in a rural primary care setting: a cross-sectional study

Medicine and pharmacy reports, 2022-07, Vol.95 (3), p.267-274

2022

Volltextzugriff (PDF)

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

Annals of the rheumatic diseases, 2019-06, Vol.78 (6), p.736-745

2019

Volltextzugriff (PDF)

Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al

Annals of the rheumatic diseases, 2024-09, Vol.83 (11), p.e25-e25

2024

Volltextzugriff (PDF)

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus

Annals of the rheumatic diseases, 2021-06, Vol.80 (6), p.758-766

2021

Volltextzugriff (PDF)

Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece

Annals of the rheumatic diseases, 2017-12, Vol.76 (12), p.1992-2000

2017

Volltextzugriff (PDF)

Changing paradigms in the treatment of systemic lupus erythematosus

Lupus science & medicine, 2019-01, Vol.6 (1), p.e000310-e000310

2019

Volltextzugriff (PDF)

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study

Frontiers in immunology, 2023-01, Vol.13, p.1074044

2023

Volltextzugriff (PDF)

In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment

Annals of the rheumatic diseases, 2020-02, Vol.79 (2), p.232-241

2020

Volltextzugriff (PDF)

IFNα Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion

Cell reports (Cambridge), 2018-10, Vol.25 (4), p.921-933.e5

2018

Volltextzugriff (PDF)

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity

Annals of the rheumatic diseases, 2019-08, Vol.78 (8), p.1079-1089

2019

Volltextzugriff (PDF)

Population-based studies in systemic lupus erythematosus: immune thrombocytopenic purpura or ‘blood-dominant’ lupus?

Annals of the rheumatic diseases, 2020-06, Vol.79 (6), p.683-684

2020

Volltextzugriff (PDF)

From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study

Clinical and experimental rheumatology, 2023-01, Vol.41 (1), p.74

2023

Volltextzugriff (PDF)

Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al

Annals of the rheumatic diseases, 2024-09, Vol.83 (10), p.e19-e19

2024

Volltextzugriff (PDF)

Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients

Lupus, 2024-10, Vol.33 (11), p.1248-1253

2024

Volltextzugriff (PDF)

Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives

Expert review of clinical immunology, 2021-04, Vol.17 (4), p.317-330

2021

Volltextzugriff (PDF)

Chloroquine as alternative antimalarial in systemic lupus erythematosus. Response to ‘2019 update of the EULAR recommendations for the management of SLE: don’t forget chloroquine’ by Figueroa-Parra et al

Annals of the rheumatic diseases, 2020-09, Vol.79 (9), p.e115-e115

2020

Volltextzugriff (PDF)

Response to: ‘Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus’ by Wu et al

Annals of the rheumatic diseases, 2022-05, Vol.81 (5), p.e76-e76

2022

Volltextzugriff (PDF)

Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy

BMC genomics, 2023-04, Vol.24 (1), p.207-207, Article 207

2023

Volltextzugriff (PDF)

2008–2018: a decade of recommendations for systemic lupus erythematosus

Annals of the rheumatic diseases, 2018-11, Vol.77 (11), p.1547-1548

2018

Volltextzugriff (PDF)

Hydroxychloroquine dosing in systemic lupus erythematosus: response to ‘Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al’ by Costedoat-Chalumeau et al

Annals of the rheumatic diseases, 2020-08, Vol.79 (8), p.e91-e91

2020

Volltextzugriff (PDF)

Response to: ‘Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus’ by Rua-Figueroa and Erausquin

Annals of the rheumatic diseases, 2020-10, Vol.79 (10), p.e132-e132

2020

Volltextzugriff (PDF)

Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up

Rheumatology (Oxford, England), 2018-08, Vol.57 (8), p.1494-1495

2018

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(83)
Buchkapitel
(2)

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(61)
Science & Technology
(61)
Rheumatology
(56)
Lupus
(48)
Systemic Lupus Erythematosus
(44)
Humans
(40)
Patients
(33)
Adult
(24)
Female
(22)
Middle Aged
(22)
Male
(21)
Lupus Nephritis
(20)
Remission
(14)
Diagnosis
(13)
Lupus Erythematosus, Systemic - Drug Therapy
(13)
Treatment
(13)
Lupus Erythematosus, Systemic
(12)
Arthritis
(11)
Severity Of Illness Index
(11)
Autoimmune Diseases
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Informing primary care reform in Greece: patient expectations and experiences (the QUALICOPC study)

General Practitioners’ intention to prescribe and prescribing patterns in selected European settings: The OTCSOCIOMED project

Self-efficacy, stress levels and daily style of living among older patients with type 2 diabetes in a rural primary care setting: a cross-sectional study

2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis

Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al

Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus

Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece

Changing paradigms in the treatment of systemic lupus erythematosus

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study

In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment

IFNα Impairs Autophagic Degradation of mtDNA Promoting Autoreactivity of SLE Monocytes in a STING-Dependent Fashion

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity

Population-based studies in systemic lupus erythematosus: immune thrombocytopenic purpura or ‘blood-dominant’ lupus?

From first symptoms to diagnosis of systemic lupus erythematosus: mapping the journey of patients in an observational study

Response to: Correspondence on ‘EULAR recommendations for the management of systemic lupus erythematosus: 2023 update’ by Fanouriakis et al

Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients

Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives

Chloroquine as alternative antimalarial in systemic lupus erythematosus. Response to ‘2019 update of the EULAR recommendations for the management of SLE: don’t forget chloroquine’ by Figueroa-Parra et al

Response to: ‘Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus’ by Wu et al

Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy

2008–2018: a decade of recommendations for systemic lupus erythematosus

Hydroxychloroquine dosing in systemic lupus erythematosus: response to ‘Comment on the 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus by Fanouriakis et al’ by Costedoat-Chalumeau et al

Response to: ‘Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus’ by Rua-Figueroa and Erausquin

Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up

Suchergebnisse filtern